Introduction
Homeostasis in the hematopoietic system is required in all vertebrates throughout life and requires a tight regulation of decisions between proliferation, apoptosis and differentiation of hematopoietic progenitors. All hematopoietic cells originate from the hematopoietic stem cell (HSC; Weissman, 2000) . HSCs proliferate without losing developmental potential or entering differentiation pathways through a process called selfrenewal (Watt and Hogan, 2000) . Previously, selfrenewal was considered to be a specific property of the HSC (Weissman, 2000) , but neither the daily generation of 200 Â 10 9 red cells nor stress erythropoiesis can easily be explained by this idea. Moreover, self-renewal has been found to also occur in monopotent stem cells (Verfaillie, 2002) .
Despite recent discovery of molecular stem cell signatures by expression profiling (Ivanova et al., 2002; Ramalho-Santos et al., 2002) , the molecular mechanisms governing decisions between self-renewal and commitment/differentiation remain largely unknown. Obviously, their knowledge would be crucial to the elucidation of 'stemness'. One of the main reasons for our ignorance is the paucity of suitable cellular models, in which sufficient numbers of normal, homogenous progenitors can be analysed in either a self-renewal or a differentiation state.
Recently, we described a cellular model system in which self-renewal can be investigated, designated T2ECs (Gandrillon et al., 1999) . T2ECs are immature erythroid progenitors expanded from the bone marrow of 19 days old chicken embryos. These cells undergo long-term (430 days) proliferation in the absence of overt differentiation, driven by a combination of the EGF-receptor tyrosine kinase ligand transforming growth factor (TGF) a, the receptor serine kinase ligand TGF-b and the glucocorticoid receptor ligand dexamethasone. At any time during culture as immature progenitors, exposure of the cells to differentiation conditions (anemic chicken serum (ACS, containing chicken erythropoietin (Kowenz et al., 1987) ) plus insulin) induces T2ECs to terminally differentiate into fully mature erythrocytes. Despite their self-renewal capacity, T2ECs are restricted to the erythroid lineage (Gandrillon et al., 1999; this paper) . This monopotency may be an advantage to study renewal, since the molecular changes governing the choice between selfrenewal versus differentiation will not be blurred by changes characteristic for lineage choices during commitment.
T2ECs display two major characteristics that distinguish them from renewing erythroid progenitors so far described in mammals: (i) they are strictly dependent upon the cooperative action of TGF-a and TGF-b, neither of which seems to be involved in renewal of mammalian hematopoietic progenitors, and (ii) they display a more immature phenotype including expression of stem cell markers and a lower tendency to spontaneously differentiate (Gandrillon et al., 1999; Bauer et al., 2001) . Therefore, T2ECs can be considered as early immature TGF-a/TGF-b driven selfrenewing progenitors, whereas their mammalian counterparts von Lindern et al., 2001 ) resemble more mature, EpoR/c-kit-driven renewing erythroid progenitors described also in the chicken system . Two cooperating signalling pathways have been implicated to date in the renewal of mammalian progenitors: the EpoR-Stat-5 and the c-kit-PI3K pathways (von Lindern et al., 2001) .
In this paper, we analysed whether similar or different signalling pathways were involved in the self-renewal of early immature chicken progenitors. Using an inhibitorbased strategy, we have identified the Ras/MEK-1/ ERKs transduction pathway as a specific key player in our self-renewing cells. We show here that the MEK-1 pathway is exclusively required for the self-renewal of T2ECs, whereas its impairment has no effect on terminal differentiation as analysed by multiple differentiation parameters. Inhibition of the MEK-1 pathway in self-renewing T2ECs causes apoptosis, since the cells exit from the self-renewal program and initiate a differentiation program in the absence of differentiation factors.
The MEK-1/ERK/MAPK signalling pathway represents the cooperation of different signal transducers in an activation cascade, linking receptors to gene activation (Ras-Raf-MEK-1-ERK1/ERK2-target genes (Chang and Karin, 2001; Johnson and Lapadat, 2002) . Despite detailed characterization of the molecular features and interactions of the proteins constituting the MAPK pathway, (Heinrich et al., 2002; Pouyssegur et al., 2002; Schoeberl et al., 2002) , the resulting cellular readouts produced by MAPK pathway activation are essentially unpredictable, being highly dependent upon the cell type, state of differentiation, model system used and precise conditions under study. For example, transient or sustained activation of the MAPK pathway can induce opposing cellular outputs such as proliferation or differentiation (Marshall, 1995) .
In different culture models of erythroid progenitor, conflicting results have been obtained with respect to the role of the ERK/MAPK pathway (Nagata et al., 1998; Matsuzaki et al., 2000; Witt et al., 2000; von Lindern et al., 2001) . Notably, this pathway seemed to be fully dispensable for the EpoR/c-kitdriven renewal of primary mammalian erythroid progenitors (Von Lindern et al., 2001) . We addressed this problem in our chicken erythroblast system in which progenitors of different maturity (early and late progenitors) can be turned into each other, by simple exposure to different cytokine/hormone combinations (Bauer et al., 2001) . Thereby, we provide a possible explanation to these discrepancies, showing that different signalling transduction pathways are involved in the renewal of either late or early progenitors, activated by different combinations of ligand-activated cell surface receptors. Our results also demonstrate the extensive plasticity of signal transduction pathway utilization in the same cell type under different environmental conditions.
Results

Screening strategy for signalling pathways using pharmacological inhibitors
Since the signalling pathways involved in controlling self-renewal or differentiation in T2ECs were essentially unknown, we devised a screening strategy using a panel of low molecular weight signalling inhibitors with known specificity. Specifically, we explored:
1. the ability of a given compound to alter the selfrenewal ability of our cells, by measuring cell proliferation via cumulative cell numbers in the presence of increasing concentrations of that compound; 2. the ability of a given compound to affect differentiation of T2ECs, by analysing their differentiation kinetics during 6 days.
Using this strategy we assessed the biological function of 13 different compounds ( Figure 1a ). We were able to group the molecules into three general classes: (i) those having no effect, (ii) those affecting either one of the two processes, and (iii) those affecting both self-renewal and the differentiation ability of T2ECs (Figure 1b) .
Among the second category, only three molecules qualified for a self-renewal specific inhibitory activity. This included the farnesyl-transferase inhibitor L-739,749 (Kohl et al., 1994) and the MEK-1-specific inhibitors PD98059 and U0126. A few interesting leads (including the role of the PI3K pathway) were not further pursued in the present work. Instead we focused on the Ras/MEK-1/ERK-MAPK pathway since conflicting results exist with respect to its role in erythropoiesis (Nagata et al., 1998; Matsuzaki et al., 2000; Witt et al., 2000; von Lindern et al., 2001) and since it was the only self-renewal-specific pathway identified.
MEK-1 inhibitors selectively inhibit self-renewal
First, we tested MEK-1 inhibitors in parallel cultures, maintained either in self-renewal or in differentiation media. All three inhibitors interfered with T2ECs proliferation under self-renewal conditions in a concentration-dependent fashion (Figure 2a, c, e) . In contrast, differentiation was not affected as estimated by acidic benzidine staining, a sensitive method to detect hemoglobin (Figure 2b, d, f) . Since this staining method is not sufficient to demonstrate a normal erythroid differentiation program, we examined T2ECs undergoing differentiation in the absence or presence of the three inhibitors for a number of other differentiation parameters including cell cycle parameters, TUNEL-positive apoptotic cells, decrease in mean cell size, expression induction of the JS4 antigen (specific for more mature erythroid cells) and loss of the immature-specific BEN antigen. None of those parameters showed any significant variations between T2ECs induced to differentiate in presence or absence of the three compounds under examination (data not shown). This establishes that a normal erythroid differentiation process could occur with an impaired Ras/MEK-1/ERKs signalling pathway.
U0126, PD98059 or L-739,749 induces cell death by apoptosis in self-renewing T2ECs
We then analysed the cellular processes through which the inhibition of the Ras/MEK-1/ERKs pathway resulted in the impairment of the self-renewal ability of T2ECs. For this, we first confirmed by a trypan blue exclusion assay that the addition of MEK-1 inhibitors induced a decrease in the overall number of viable cells (Figure 3a) . This reduction in cell number did not result from a block in a given phase of the cell cycle, since the cell cycle parameters as assessed by propidium iodide staining were identical in either treated or untreated cells (Figure 3b ). We showed that this reduction was due to an increase in the fraction of cells undergoing cell death since the addition of both inhibitors induced a strong increase in the percent of cells undergoing apoptotic cell death as shown by an increase in apoptotic markers specific for both early (DNA breaks detected in the TUNEL assay; Figure 3c ) and late phases of apoptosis (a sub-G1 peak indicating DNA condensation; Figure 3d ).
In conclusion, inhibition of the Ras/MEK-1/ERKs pathway leads to a significant and reproducible increase of apoptosis in self-renewing T2ECs.
Increase in apoptosis is due to an exit from the self-renewal program
The observed increase in apoptosis could originate from two different mechanisms. First, the Ras/MEK-1/ERKs pathway might be responsible for a self-renewal-specificsurvival program. Alternatively, inhibition of the Ras/MEK-1/ERKs pathway might lead to a premature exit from self-renewal and entry into a differentiation These two hypotheses can be easily distinguished experimentally. According to the first idea, concomitant addition of self-renewal and differentiation factors should not lead to significant protection against apoptosis induced by MEK-1 inhibitors. If the second hypothesis is true, however, simultaneous addition of self-renewal plus differentiation factors to cells treated with the MEK-1 inhibitors should protect them against apoptosis and induce them to differentiate.
T2ECs treated with combined self-renewal and differentiation factors showed no increased apoptosis upon inhibition of the MEK-1 pathway (Figure 4a ). On the contrary, we observed an increase in their differentiation level as assessed by JS4 cell surface expression level and globin gene expression ( Figure 4a ). Differentiation under these conditions was incomplete, showing neither complete downregulation of immature-specific MEP antigens nor strong hemoglobin staining with neutral benzidine (data not shown). This is most likely due to the fact that the proliferation plus differentiation medium contained Dex and that full differentiation requires turning off signalling via the glucocorticoid receptor (GR; Wessely et al., 1997) . In order to investigate the potential role of GR and of TGF-b in this process, we have analysed the behavior of cells grown in the presence of differentiation factors, plus TGF-a, plus a neutralizing anti-TGF-b antibody (to fully interrupt the action of autocrinely produced TGF-b; Gandrillon et al., 1999) plus RU486 to block GR function. Under these conditions, the differentiation of T2ECs was virtually complete and not affected by the addition of a MEK-1 inhibitor (data not shown).
To control whether MEK-1 inhibitor-induced partial differentiation occurred early enough to be detected even in the absence of differentiation inducers (i.e. before significant apoptosis occurs), we analysed the The MEK-1 signalling pathway is required for self-renewal in early but not late avian erythroid progenitors
One of the advantages of the avian system is the existence of several erythroid progenitors types that can be selectively expanded in various combinations of factors and hormones (Bauer et al., 2001) . This offers the unique opportunity to explore, whether induction of renewal by completely different exogenous signals (TGF-a/TGF-b/Dex versus Epo/SCF/Dex) proceeds via activation of similar or different signalling pathways.
Having established that the MEK-1/ERK/MAPK pathway is necessary for renewal of T2ECs, we therefore analysed its requirement for renewal in EpoR progenitors . EpoR progenitors differ from T2ECs by their requirement for Epo, SCF and Dex, by their more mature erythroblast phenotype as assessed by analysing stage-specific surface antigens (Gandrillon et al., 1999; Wessely et al., 1999) , and by a higher tendency to undergo spontaneous differentiation (i.e. differentiation in the renewal conditions; Wessely et al., 1999) . EpoRprogenitors contain only minute amounts of the EGF-R (only detectable by RT-PCR), but gradually upregulate the EGFR to high levels if maintained in TGF-a, SCF, estradiol, and Dex, switching them to a phenotype resembling T2ECs (Hayman et al., 1993; Steinlein et al., 1995) .
We first verified that the renewal of EpoR progenitors was indeed insensitive to MEK-1 inhibition as previously described (Gandrillon et al., 1999; Figure 5a ). In contrast, when these cells were switched to a medium containing TGF-a, TGF-b and Dex (T2ECs medium) and cultivated in this medium for E6 days, they became sensitive to the inhibitors (Figure 5b ) just like normal T2ECs.
The reverse experiment confirmed the above results: T2ECs expressing the murine Epo receptor via an avian retroviral vector (Steinlein et al., 1994; Wessely et al., 1999) and grown in LM1 medium were fully sensitive to the self-renewal inhibition by PD98059 or UO126 treatment (Figure 5c ). Nevertheless, the same culture clearly lost this sensitivity when the cells were switched to EpoR medium (Figure 5d ). This was accompanied by the appearance of a more mature phenotype as indicated by a high level of spontaneous differentiation assessed by acid benzidine staining (20% of positive cells, data not shown). The same switch to more mature cells also attenuated MEK-MAPK signalling. When erythroid progenitors expressing the murine Epo receptor were switched from LM1 medium to EpoR medium, a sharp decline in the steady-state activity of the MEK-1 pathway was observed (as determined using phosphospecific ERK/MAPK antibodies, data not shown). In conclusion, these data demonstrate a striking plasticity of erythroid progenitors with respect to utilization of signalling pathways during renewal, dependent on state of maturation and exposure to different external signals.
The MEK-1 pathway is under the control of TGF-a The next question addressed was which of the selfrenewal factors (i.e. TGF-a, TGF-b or Dex) was responsible for activating the MEK-1 pathway. For this, T2ECs were deprived from all factors and restimulated with physiological doses of each factor alone or in combination. It was immediately apparent that TGF-a addition was responsible for the MEK-1 induction in our cells, with no contribution, either positive or negative, of TGF-b nor dexamethasone (Figure 6a) .
We verified that the absence of visible MEK-1 stimulation by TGF-b or dexamethasone was not due to different kinetics of pathway activation or to inappropriate doses of these factors, since response kinetics (20 s to 8 h) performed with TGF-b or dexamethasone in large excess did not cause significant ERK phosphorylation at any of these conditions (data not shown).
Thereafter, a dose-response analysis of TGF-ainduced MEK-1 activation was performed. Strong phosphorylation of ERK could be detected with a TGF-a dose as low as 0.25 ng/ml, while 0.05 ng/ml of TGF-a resulted in weak activation (Figure 6b) . Thus, the steady-state amount of TGF-a in self-renewal medium (5 ng/ml) is both necessary and sufficient for inducing a high level of MEK-1 activation in T2ECs. This dose corresponds to saturating doses in other systems and was therefore used throughout all biochemical assays.
We then investigated the extent to which TGF-ainduced ERK phosphorylation paralleled its biological activity. TGF-a concentrations as low as 0.25 ng/ml were sufficient to promote sustained T2ECs proliferation, although after some initial lag period, while cells proliferated without a lag phase at higher TGF-a concentrations (Figure 6c ). TGF-a concentration (0.05 ng/ml) was just sufficient to allow survival of sparse T2ECs, but failed to induce a net increase of cell number. Thus, induction of ERK phosphorylation by TGF-a perfectly correlated with the ability of TGF-a to induce cell proliferation, supporting the existence of a functional link between those two events. We also determined the kinetics of TGF-a-induced MEK-1 activation. A biphasic response (Figure 6d ) as previously described in other cell systems was observed (Bourgin et al., 2000) . At 24 h after TGF-a readdition, the level of phosphorylated ERK had returned to a low, basal level (see Figure 7a) .
Taken together these results establish that the ERK/ MAPK pathway in self-renewing T2ECs is under the exclusive control of TGF-a, and that the degree of ERK/ MAPK phosphorylation (as a measure of pathway activity) exactly mirrors the effects of TGF-a on renewal.
We then analysed the effects of inhibitor addition on TGF-a-induced ERK/MAPK pathway activation as measured by ERK1/2 phosphorylation. We observed that both PD98059 and U0126 completely abolished the ERK phosphorylation, whereas LY294002, an inhibitor of the PI3 kinase pathway (Vlahos et al., 1994) had no effect upon the level of ERK phosphorylation (Figure 6e ). The addition of the farnesyl-transferase inhibitor L-739,749 completely abolished both the early and the late TGF-a-induced ERK phosphorylation (Figure 6f ). This strongly supports the idea that TGFa activates the avian EGF-receptor c-ErbB, (Steinlein et al., 1995) which then activates the Raf/MEK1/ERK MAPK pathway via Ras signalling (Bogdan and Klambt, 2001 ).
The MEK-1 pathway can be activated by differentiationinducing factors
Since MEK-1 inhibition did not affect T2ECs after induction of erythroid differentiation, we wanted to know whether the MEK-1 pathway is active but not required, or inactive, in differentiating T2ECs. We therefore analysed the ability of the differentiationinducing factors to activate signalling through the ERK/ MAPK pathway.
Cells were starved and stimulated with ACS and insulin, either alone or in combination. A very faint MEK-1 activation could be detected under those conditions (Figure 7a) . Then, by performing kinetic analysis, we demonstrated that the MEK-1 pathway could be activated with a similar biphasic response by differentiation-inducing factors, albeit with a lower efficiency than by TGF-a (Figure 7b ). We further showed that the activation seen was not due to general serum factors, since sera lacking erythropoietic activity such as foetal calf serum (FCS) or non-ACS, failed to cause ERK-phosphorylation (Figure 7a ). These data demonstrate that the biological consequences of ERK/ MAPK-pathway activation are dependent on cellular context, and that activation of this pathway is possible but not required during terminal differentiation activation.
Constitutive MEK-1 activation inhibits T2ECs differentiation
We then asked whether a constitutive activation of this MEK-1 pathway might impair the differentiation process, similarly to what has previously been shown for Ras ectopic expression (Kahn et al., 1986) . For this, T2ECs were infected with a retroviral vector expressing MEK-1DD, a constitutively active form of MEK-1 Pages et al., 1994) . We observed that the expression of MEK-1DD allowed the sustained proliferation of T2ECs in the absence of growth factors such as TGF-a (not shown). In line with this, we also observed that the differentiation process was severely impaired in cells expressing a constitutively active form of MEK-1 (Figure 8) .
Those data reinforce the importance of a proper regulation of the MEK-1 signalling pathway in the decision between self-renewal and differentiation in T2ECs. Figure 7 Western blot analysis of ERK/MAPK pathway activation by differentiation-specific factors. (a) T2ECs were starved for 3 h, both from factors and from serum, and restimulated either with LM1, ACS plus insulin (AI, 15%), FBS, 15 % or normal chicken serum (NCS, 15%) for the indicated time periods. Note that the two 24 h time points were performed in the absence of the phosphatase inhibitors. (b) T2ECs were starved for 3 h and stimulated with ACS plus insulin for the indicated time period. As a positive control, the extent of ERK phosphorylation induced by a 1 min treatment with 10 ng/ml TGF-a is shown. Blots were probed with anti-phospho-ERK1/2 antibody (upper blot), stripped and reprobed with the anti-total ERK antibody (lower blot). Co: control incubated in the presence of the phosphatase inhibitor cocktail only
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T2ECs are lineage-restricted self-renewing cells
Recently, both in chicken (Lesault et al., 2002) and murine erythroid progenitors (Dolznig et al., 2002) , terminal erythroid differentiation was shown to proceed independently of exogenous differentiation factors (Epo/Insulin) if protection of the cells from apoptosis was ensured. Interestingly, such a default mechanism was also operating in differentiating T2ECs, although these cells are more immature and are driven by completely different signal transduction pathways during renewal. T2ECs were induced to differentiate by withdrawal of all renewal factors, preventing apoptosis by addition of the general caspase inhibitor Z-VAD or through the ectopic expression of the human Bcl-2 gene (Lesault et al., 2002) . Both Bcl-2 expression and Z-VAD treatment induced a substantial delay in apoptosis, sufficient to result in a reproducible spontaneous differentiation process, as assessed by the appearance of benzidine-positive cells (data not shown) and induction of JS4 expression (see Figure 9) . Previous trials to induce T2ECs differentiation into other lineages than erythroid (by addition of myeloid cytokines or inducers of myeloid differentiation) had failed, suggesting that T2ECs were monopotent erythroid progenitors (Gandrillon et al., 1999) . It was shown earlier, however, that protection of murine multipotent progenitors (FDCP-mix) from apoptosis by Bcl-2 had allowed their differentiation into multiple lineages, in the absence of any cytokines normally required for hematopoietic differentiation (Fairbairn et al., 1993) . Our ability to induce erythroid differentiation in T2ECs in the absence of any specific inducer now allowed to determine, whether the cells that clearly expressed immature markers also present on multipotent avian progenitors (Gandrillon et al., 1999) were now able to differentiate into other hematopoietic lineage(s).
Differentiation of T2ECs was induced by the withdrawal of self-renewal factors plus the addition of either ACS þ insulin or ZVAD. Cells were then analysed for expression of erythroid and various myeloid markers by FACS analysis. While ZVAD-protected cells entered the erythroid differentiation pathway as shown by a clear increase in JS4 expression levels at the cell surface (Figure 9 ), no antigens specific for the other cell lineages examined (eosinophilic, myelomonocytic and thrombocytic) were expressed in these cells, as shown using respective antibodies (Figure 9 ). These data (also obtained in Bcl-2 expressing cells, not shown) establish that T2ECs are monopotent erythroid progenitors, despite their expression of immature cell antigens and ability to undergo sustained self-renewal.
Discussion
In this paper we show that immature erythroid progenitors (T2ECs) expanded in a combination of TGF-a, TGF-b and dexamethasone strictly require a functional Ras/MEK-1/ERK-MAPK pathway for induction and maintenance of self-renewal. This pathway, strongly activated by the c-ErbB ligand TGF-a, and more weakly by anemic but not normal chicken Figure 8 T2ECs expressing a constitutively active form of MEK-1 are impaired in terminal differentiation. T2ECs, either uninfected or infected with the RCAS-MEK-1DD virus (see Materials and methods), were induced to differentiate for 6 days. At the indicated period of time, aliquots were removed and assessed for the percentage of benzidine-positive cells. As a positive control, T2ECs were infected with the AEV virus (Samarut and Gazzolo, 1982) , which is known to completely arrest differentiation Figure 9 Lineage analysis of apoptosis-protected T2ECs differentiating in response to withdrawal of self-renewal factors. T2ECs were grown for 48 h, either in LM1 medium (gray line), or in DM17 medium (black line), or in a growth factor-depleted medium plus 100 mm ZVAD (gray shaded area). Cells were then analysed by cytofluorometry for expression of the indicated antigens (see Materials and methods). As a control, the fluorescence profile of cells incubated with the FITC-labelled goat anti-mouse secondary antibody only is shown Role of MEK-1 in immature erythroid progenitors S Dazy et al serum, is strictly required in the self-renewing cells but fully dispensable after induction of erythroid differentiation in the same cells. If signalling through the ERK/ MAPK pathway is inhibited by three different low molecular weight pharmacological inhibitors acting through different mechanisms, the cells are induced to enter the erythroid differentiation process. Conversely, constitutive activation of the MEK-1 pathway prevents the cells from exiting from self-renewal and entering a differentiation process. The requirement for erythroid differentiation factors to protect the differentiating cells from apoptosis can be completely substituted by antiapoptotic proteins (Bcl-2) or nonselective caspase inhibitors (ZVAD). Apoptosis protection of the self-renewing T2ECs also allowed to show that these cells were restricted to the erythroid lineage, despite the fact that Bcl-2 expressing murine multipotent progenitors differentiated into multiple lineages in a similar absence of cytokines (Fairbairn et al., 1993) .
Finally, we were able to demonstrate that requirement of the ERK/MAPK signalling pathway for renewal was restricted to the early T2EC progenitors, while late primary erythroid progenitors induced to self renew via Stat5-and PI3 K pathway activation, driven by the EpoR and c-Kit, respectively, undergo a (less sustained) renewal in a fashion independent of the ERK/MAPK pathway ( Figure 10) .
Self-renewal of T2ECs requires, besides TGF-a, two other external factors, namely TGF-b and dexamethasone. Therefore, one has to consider that one signalling pathway shown to be necessary only represents a small part of the more complex signalling network employed for maintaining a self-renewal state. Indeed, as shown in Figure 1b , numerous hints suggest that other known pathways are also important. These possibilities are currently being pursued.
Furthermore, TGF-b signalling is clearly involved in the maintenance of T2ECs self-renewal, through yet-tobe-discovered mechanisms, which however require signalling through the TGF-b receptor, as recently shown using specific pharmacological inhibitors of the TGFb R (HB, S Giraud, OG unpublished). Our work shows that MEK-1 activation is neither induced nor repressed under the influence of TGF-b. This suggest that the possible functional link between TGF-a and TGF-b signalling pathways most likely involves modulation of TGF-b-receptor signalling by the downstream activity of MEK1 or ERK/MAPK, thus protecting the cells from the differentiation-and cell-cycle arrest/ apoptosis inducing functions of TGF-b. Importantly, TGF-b has exactly these effects in EpoR progenitors, which are not dependent on the ERK/MAPK signalling pathway for renewal (HB unpublished results).
In T2ECs, the MEK-1 pathway is involved in the maintenance of self-renewal, since its inhibition induces the cells to exit from their self-renewal state, and since its forced activation prevents the entry into a differentiation program.
In the absence of survival signals, the exit from selfrenewal will result in the induction of apoptosis. This situation is somewhat reminiscent of the function of certain nuclear hormone receptors in chicken erythroid progenitors (Gandrillon et al., 1994; Bauer et al., 1998) . Here, activation of the thyroid hormone receptor c-ErbA caused a forced exit from renewal and entering of a (somewhat altered) differentiation program. In contrast, the dominant-negative thyroid hormone receptor mutant v-ErbA cooperates with TGF-a/TGF-bsignalling in a fashion very similar to that employed by the glucocorticoid receptor, showing that nuclear receptors can both synergize with and antagonize the self-renewal-inducing function of ERK/MAPK signalling induced by TGF-a-dependent c-ErbB activation.
Work of others addressing the role of the ERK/MAPK signalling pathway in murine and human erythroid progenitors yielded conflicting findings (Nagata et al., 1998; Matsuzaki et al., 2000; Witt et al., 2000; von Lindern et al., 2001) . In these cells, activation of MEK-1 as detected by ERK/MAPK phosphorylation was induced by erythropoietin (Epo) and the c-Kit ligand stem cell factor (SCF). While strength and kinetics of MEK-1 activation closely resembled the biochemical data obtained in T2ECs, no functional role could be assigned so far to this pathway, since pharmacological MEK-1 inhibition does not interfere with the biological activities of Epo and SCF (Somervaille et al., 2001; von Lindern et al., 2001) . The easiest way to explain this is that primary or established mammalian erythroid progenitors capable of renewal correspond more to avian EpoR progenitors, since their renewal is driven by Epo, SCF and/or high PI3K signalling pathway activity (Nishigaki et al., 2000; Tamir et al., 2000; Zochodne et al., 2000) . In contrast, erythroid progenitors whose renewal is driven by the cooperation of TGF-a/EGFR and TGF-bR signalling have not yet been described in mammalian systems. Indeed, numerous trials to detect expression of c-ErbB/ EGF-R related genes or clear biological effects by addition of EGF-family ligands have failed (U Schmidt and HB, unpublished) .
Interestingly, however, a similar plasticity as seen between T2ECs and EpoR progenitors could be demonstrated in preliminary experiments using the murine p53À/À I/11 erythroid cell line after exogenous expression of the human EGF-receptor c-ErbB/HER-1. When these cells were grown in Epo/SCF/Dex, plus a specific inhibitor of the EGFR tyrosine kinase, renewal required PI3K pathway activity while inhibition of ERK/MAPK pathway signalling by MEK-1 inhibitors did not have any effect. In contrast, when cells were grown in TGF-a plus Dex, PI3K-inhibitors no longer affected renewal (Von Lindern et al., 2001) , while MEK-1 inhibitors interfered with renewal under these conditions (HB unpublished). However, the fact that these cells overexpress an exogenous EGFR and our ignorance about the role of TGF-b R signalling in renewal induction so far precludes a direct comparison of this murine cell model with avian T2ECs.
In conclusion, we have established that the biological readout of the ERK/MAPK pathway critically depends on the cellular context, for instance, progenitor maturity. In turn, this cellular context shows an impressive degree of plasticity, being modulated by different external signals. Such external signals can strongly modulate the expression of receptor tyrosine kinases (Steinlein et al., 1995) , and, as shown here, the biological response to activated signalling pathways downstream of receptor tyrosine kinases. Consequently, the conflicting data concerning the role of the MEK-1 pathway in closely related erythroid cell systems can be explained by progenitor plasticity, in response to different external signals or in erythroid cell lines, as a consequence of changes occurring during immortalization.
Given this complex, plastic behaviour of erythroid progenitors, a possible approach to understand the different biological readouts of a given signalling pathway in different cellular contexts may be the determination of the target gene spectra regulated by this pathway. We are currently studying this issue through a SAGE approach (serial analysis of gene expression; Velculescu et al., 1995) , in order to obtain an exhaustive view of the fraction of the transcriptome that is under the control of the MEK-1 pathway in self-renewing T2ECs. This will also allow comparing the network of genes involved with the increasing body of transcriptomic data generated in other self-renewing cell systems.
Materials and methods
Reagents
TGF-a and TGF-b1 were purchased from PeproTech as a lyophilized human recombinant protein and resuspended as previously described (Gandrillon et al., 1999) . PD98059 (Dudley et al., 1995) was a gift from Dr M Von Lindern (Institute of Hematology, Erasmus University, Rotterdam). U0126 (Favata et al., 1998) was purchased from Promega. ZVAD-fmk (Chow et al., 1995) was purchased from Calbiochem. The recombinant avian SCF (aSCF) was prepared as described (Bartunek et al., 1996) .
Antibodies
The MEP 26, MEP 17, JS4, EOS47, MYL 51/2, BEN antibodies have been previously described (Gandrillon et al., 1999) . The 11C3 (Lacoste-Eleaume et al., 1994) and LIBS6 (Frelinger et al., 1991) antibodies were kind gift or Dr P Que´re( INRA, Nouzilly) and Dr H Ginsberg (La Jolla, CA, USA), respectively. Both antibodies recognize antigens expressed specifically on the thrombocytic lineage.
Cells
T2ECs were generated from SPAFAS white leghorn chickens (PA12 line from INRA at Tours, France) as previously described (Gandrillon et al., 1999) . EpoR cells were grown after infection of SPAFAS bone marrow cells with a murine Epo-Receptor-expressing virus as previously described .
Retroviruses
The following viruses were generous gifts from Dr Jacques Ghysdael and Dr Christine Tran Quang (Institut Curie, Orsay): RCAS-bcl2, carrying the human bcl2 (Lesault et al., 2002) , and RCAS-A (BP) as a helper virus together with the pCRNCM-EpoR construct expressing the murine Epo receptor (Quang et al., 1997) . The viruses were produced through transfection of chicken embryo fibroblasts (CEFs). The ectopic expression of bcl2 was verified by Western blot analysis as previously described (Lesault et al., 2002) . The ectopic expression of the Epo receptor was verified by real-time PCR.
The constitutive active form of MEK-1 known as MEK-1DD Pages et al., 1994) was a generous gift from Dr Alain Eyche`ne (Institut Curie, Orsay). It was subcloned into a RCAS A(BP) vector, and produced through transfection of CEFs. Infected T2ECs overexpressing a constitutive active form of MEK-1 were selected by their ability to proliferate in the absence of growth factors (LM1 devoid of TGF-a, TGF-b and Dex). The ectopic expression of the HA-tagged MEK-1 DD was verified by Western blot analysis as previously described Pages et al., 1994) .
The AEV virus (ES4 strain) has been previously described (Gandrillon et al., 1987) .
Infection of primary erythroblasts with retroviruses
For generating EpoR cells, chicken bone marrow cells were cocultivated for 2 days with CEFs transfected with the respective retroviral constructs. During infection, cells were grown either in LM1 medium (Gandrillon et al., 1999) or in EpoR medium as previously described with slight modifications (a-MEM plus 10% FBS; 1% penicillin þ streptomycin; 10 À3 m HEPES; 10 À4 m b-mercaptoethanol; 100 ng/ml aSCF; 1 mm dexamethasone; 40 ng/ml IGF-1 (R&D) and 5 U/ml rhEPO (Roche). When applicable, infected cells were selected by G418 (3 mg/ml) for 5 days and amplified either in LM1 medium or in EpoR medium.
In the case of infection with the RCAS-MEK-1 DD and the AEV viruses, a direct infection protocol was used (Samarut and Gazzolo, 1982) .
Growth measurement
Cell numbers were estimated after seeding 100 ml-aliquots of cells at 2 Â 10 5 cells/ml in 96-well plates in the presence of indicated concentrations of inhibitors. Cells were grown for 48 h and numbered using the WST-1 assay (Roche) according to the manufacturers instructions.
Differentiation assay
Exponentially growing T2ECs were suspended at a concentration of 10 6 cells/ml in differentiation medium as previously described (Gandrillon et al., 1999) . The preparation of ACS as well as the estimation of the level of differentiation by acidic Role of MEK-1 in immature erythroid progenitors S Dazy et al benzidine staining have been previously described (Gandrillon and Samarut, 1998) .
Flow cytometric analysis
Cell surface antigens detection and cell cycle analysis were performed as previously described (Gandrillon et al., 1999) . TUNEL assay (in situ cell death detection kit TMR red; Roche) was performed according to the manufacturer's instructions, with the following modification: cells were fixed with formaldehyde and permeabilized with 0.1% Tween-20. Fluorescence data acquisition was done using a FACSCalibur flow cytometer and analysis was performed using the CELLQuest program (both from Becton-Dickinson).
Western blot analysis
Cells were washed once with aMEM containing 10% FBS and incubated for 3 h at a density of 10 7 cells/ml in a factordepleted medium (LM1 without TGF-a, TGF-b, dexamethasone and supplemented with 2 mm mifepristone (Sigma) to inhibit glucocorticoid signalling and with 20 ml per ml of a neutralizing monoclonal mouse anti-TGF-b1,2,3 (Genzyme) in order to neutralize the TGF-b autocrine loop (Gandrillon et al., 1999) . Cells were then stimulated under 1 ml of appropriate medium containing 1% phosphatase inhibitor cocktail 2 (Sigma) at 371C.
Stimulation was stopped in 9 ml of cold PBS containing 1 mm sodium orthovanadate. After centrifugation for 5 min at 1500 r.p.m., cell pellets were frozen in liquid nitrogen. Frozen pellets were lysed on ice in glycerol 10%, Triton X-100 1%, NaCl 150 mm, KCl 5 mm, EDTA 1 mm, HEPES 50 mm pH 7.5 supplemented with 1% phosphatase inhibitor cocktail 2 (Sigma) and complete mini EDTA-free protease inhibitor cocktail (Boehringer). The lysates were cleared by centrifugation for 10 min at 12 000 g and protein concentration was determined by using the Dc protein assay from Bio-Rad.
Proteins were denatured in Laemmli blue (0.5 m Tris-HCl, pH 6.8; 10% glycerol, 10% SDS, 0.1% bromophenol blue, 5% bmercaptoethanol) for 10 min at 991C. At least 20 mg of proteins were resolved in a sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 7.5 % acrylamide gels and blotted on Protan BA85 Nitrocellulose membranes. These membranes were blocked in 5% nonfat Milk, 0.1% Tween-20 tris-buffered saline (TBS) at room temperature for 1 h and then probed with primary antibodies diluted in TBS supplemented with 5% bovine serum albumine (BSA; Sigma) and 0.1% Tween-20 for 1 h at room temperature. The membranes were washed twice in TBS containing 0.1% Tween-20.
Bands were visualized using the Supersignal West Pico chemiluminescent substrate (Pierce) after 1 h incubation with a horseradish-peroxidase-coupled secondary anti-rabbit IgG antibody (Amersham NA934) diluted 1 : 10 000 in TBS 5% BSA, 0.1% Tween-20 or with a horseradish-peroxidasecoupled secondary anti-mouse IgG antibody (Rockland 610-703-124) diluted 1 : 10000 in TBS 5% BSA, 0.1% Tween-20.
Whenever needed, the membranes were stripped using a glycine buffer (0.1 m, pH 2.5) for 1 h at RT and washed two times with TBST. Membranes were then reprocessed as previously described.
The following primary antibodies were used: a rabbit antiphospho p44/42 MAPK (Cell Signalling Technology), used at 1 : 1000; a rabbit anti-ERK1.2 and 3 (M5670 from Sigma) used at 1 : 10000, and a mouse monoclonal antibody anti-HA (clone 12CA5 from Roche) used at 1 : 500.
Real-time RT-PCR
RNA extraction and reverse transcription assay were performed as previously described (Gandrillon and Samarut, 1998) . Real-time PCR was done according to the manufacturer's instructions (Quantitectt SYBR s Green PCR; Qiagen). In order to assess the quality and the efficiency of the RT reactions, we checked for the expression of two invariant genes, namely BBC1 (GenBank accession number: D26318) and ubiquitin (GenBank accession number: X02650) as internal standards. RT samples were considered as valid when both BBC1 and ubiquitin real-time PCR gave Ct values with variations of less than 1/2 Ct between the samples.
In order to quantify gene expression, standard curves were generated, for each pair of primers, by dilution series (1/2, 1/4, 1/8, 1/16), the sample displaying the highest expression rate was used as a relative standard. These standard curves were then used to determine the relative amount of the sample displaying the lowest expression rate.
For information about the specific PCR conditions and primers sequences used, please contact the authors.
